About Seranova
Seranova is a Healthcare company based in New Haven (United States) founded in 2020. CRO offering chemical proteomics services for preclinical development of drug. Seranova has raised $10 million across 1 funding round. Seranova offers products and services including REAP Technology. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and Chemical Proteomics. Its competitors include Liberation Labs, NJ Bio and Peplib; 2 of its 3 listed competitors have raised funding.
Company details
Seranova was founded in 2020 and is based in New Haven, United States. As a contract research organization in the biotechnology sector, chemical proteomics services are provided by the company to support preclinical drug development. Operations focus on analytical techniques that enable target identification and validation in early-stage pharmaceutical research, serving clients in the life sciences industry.
- Headquarters New Haven, United States
- SectorsHealthcare
- Website seranovabio.com
- Social LinkedIn
- Total Equity Funding$10M (USD)
in 1 rounds
- Latest Funding Round$10M (USD), Series A
Feb 2024
Products & Services of Seranova
Seranova offers a comprehensive portfolio of products and services, including REAP Technology.
Analyzes autoantibodies in blood to discover new disease therapeutics.
Funding Insights of Seranova
Seranova has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Series A round of $10 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $10M
- Total Rounds 1
- Last Round Series A — $10M
- First Round $10M
(Feb 2024)
All 1 funding rounds of Seranova with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2024 | $10M | Series A | – | – | – |
People of Seranova
6 people are tracked at Seranova (4 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Brent McKenzie | Chief Scientific Officer | Leadership |
Aaron Ring | Founder | Leadership |
Leon Furchtgott | Senior Director, Data Science and Machine Learning | Leadership |
Sean Carroll | Vice President | Leadership |
Joe Derla | Associate Scientist | Team |
Emi Lutz | Scientist II | Team |
Complete people profiles for Seranova
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Seranova
2 dated milestones of Seranova across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Seranova is founded.
- Funding First funding round of $10.0M.
Competitors of Seranova
Seranova has 3 listed competitors in our database, 2 of them funded. They include Liberation Labs, NJ Bio and Peplib.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| liberationlabs.com | 2022 | New York, United States | $107.61M | Fermentation products are manufactured and commercialized via CRO services. | ||
| njbio.com | 2018 | North Brunswick, United States | 84 | Clinical development services are provided for biotechnology applications. | ||
| peplib.com | 2017 | Boston, United States | $34.22M | Provider of peptide drug discovery and development services for global pharmaceutical industries |
Detailed competitors of Seranova
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Seranova
The website of Seranova (seranovabio.com) receives about 3K visits a month.
- Monthly visits3K
▲ 13.1% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Seranova (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Seranova
Complete news archive for Seranova
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Seranova
Seranova was founded in 2020 and raised its 1st funding round 4 years after it was founded.
Seranova is headquartered in New Haven, United States. It is registered at New Haven, Connecticut, United States.
Seranova is a funded company, having raised a total of $10M across 1 funding round to date. The company's 1st funding round was a Series A of $10M, raised on Feb 2024.
Seranova was founded in 2020 and is based in New Haven, United States. As a contract research organization in the biotechnology sector, chemical proteomics services are provided by the company to support preclinical drug development. Operations focus on analytical techniques that enable target identification and validation in early-stage pharmaceutical research, serving clients in the life sciences industry.
Seranova's top competitors include Liberation Labs, NJ Bio and Peplib.
Seranova offers REAP Technology.